These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 820462)

  • 1. [Antitumoral immunity induced by the administration of homologous and isologous tumoral cells treated by moderate heating].
    Bourdon G; Halpern B
    C R Acad Hebd Seances Acad Sci D; 1976 Apr; 282(16):1571-6. PubMed ID: 820462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibition of tumoral graft growth by pretreatment with normal or heat-modified tumoral cells].
    Bourdon G
    Ann Immunol (Paris); 1981; 132C(1):43-63. PubMed ID: 7259112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of the immune response to transplantation antigens. III. Further studies on the effects of Freund's complete adjuvant on the immune response of mice to allogeneic tumour antigen.
    Zola H
    Clin Exp Immunol; 1974 Mar; 16(3):469-79. PubMed ID: 4157121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect on the growth of BP8 ascites tumour in C3H-C57 or C3H mice of "lymphocyte preparations" from C57 mice injected with BP8 cells and Freund's adjuvant.
    Cater DB; Waldmann H
    Br J Cancer; 1967 Mar; 21(1):124-36. PubMed ID: 6024503
    [No Abstract]   [Full Text] [Related]  

  • 5. Suppression of cell-mediated antitumor immunity by complete Freund's adjuvant.
    Koyama S; Yoshioka T; Sakita T
    Cancer Res; 1982 Aug; 42(8):3215-9. PubMed ID: 6980047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Stimulation of immunity to isologous transplantable hepatoma 22a and 46 using Freund's adjuvant in C3HA mice].
    Orlov AB
    Vopr Onkol; 1970; 16(2):51-3. PubMed ID: 4314786
    [No Abstract]   [Full Text] [Related]  

  • 7. Peritoneal cell populations during tumour injection.
    De Heer E; De Groot JW; Den Otter W; Dullens HF
    Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in the protective effect of complete Freund's adjuvant in spontaneous versus transplanted lymphomas in AKR mice.
    Check JH; Brady LW; O'Neill EA
    Prog Exp Tumor Res; 1974; 19():217-21. PubMed ID: 4438641
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody-mediated immunity to transplantable tumors following reovirus oncolysis.
    Klein PA
    Pathol Microbiol (Basel); 1967; 30(2):222-45. PubMed ID: 4291735
    [No Abstract]   [Full Text] [Related]  

  • 10. Dissociation between cytotoxic activity and delayed hypersensitivity against syngeneic or allogeneic tumor grafts.
    Sato M; Nomoto K; Yano Y; Taniguchi K; Takeya K
    Gan; 1976 Dec; 67(6):835-47. PubMed ID: 1088135
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection of mice from malignant tumor implants by enucleated tumor cells.
    Sethi KK; Brandis H
    J Natl Cancer Inst; 1974 Oct; 53(4):1175-6. PubMed ID: 4372368
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunological characteristics of leukemia and lymphoma in allogeneic cell immunity: growth of syngeneic tumors in rats immunized with allogeneic cells.
    Hosokawa M; Yamashita T; Gotohda E; Takeichi N; Kodama T; Kobayashi H
    Int J Cancer; 1978 Jul; 22(1):91-7. PubMed ID: 681026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early growth of experimental tumors and the onset of concomitant immunity.
    karakousis CP; Paolini NS; Sharma SD; Moore RH
    Eur J Cancer Clin Oncol; 1982 Feb; 18(2):211-7. PubMed ID: 6284514
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of immune responses to spontaneous hamster lymphomas.
    Vasa-Thomas KA; Ambrose KR; Bellomy BB; Coggin JH
    J Natl Cancer Inst; 1977 May; 58(5):1287-93. PubMed ID: 67210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.
    Kearney R; Nelson DS
    Aust J Exp Biol Med Sci; 1973 Dec; 51(6):723-35. PubMed ID: 4788454
    [No Abstract]   [Full Text] [Related]  

  • 16. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced tumor growth in animals pretreated with complete Freund's adjuvant.
    Meltzer MS; Leonard EJ
    J Natl Cancer Inst; 1973 Jan; 50(1):209-18. PubMed ID: 4348220
    [No Abstract]   [Full Text] [Related]  

  • 18. Structurally well-defined macrophage activating factor derived from vitamin D3-binding protein has a potent adjuvant activity for immunization.
    Yamamoto N; Naraparaju VR
    Immunol Cell Biol; 1998 Jun; 76(3):237-44. PubMed ID: 9682967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A critique of the evidence for active host defence against cancer, based on personal studies of 27 murine tumours of spontaneous origin.
    Hewitt HB; Blake ER; Walder AS
    Br J Cancer; 1976 Mar; 33(3):241-59. PubMed ID: 773395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local and systemic effects in the non-specific tumour resistance induced by attenuated Salmonella enteritidis 11RX in mice.
    Ashley MP; Neoh SH; Kotlarski I; Hardy D
    Aust J Exp Biol Med Sci; 1976 Apr; 54(2):157-68. PubMed ID: 797377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.